GI
MXCT icon

GAMMA Investing’s MaxCyte MXCT Stock Holding History

GAMMA Investing’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.01K Buy
5,702
+269
+5% +$268 ﹤0.01% 3349
2026
Q1 		$3.82K Buy
+5,433
New +$5.07K ﹤0.01% 3469

Other funds holding MXCT

MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
KL
KWMG LLC Overland Park, Kansas $1.38B AUM 33.35% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

GAMMA Investing's MXCT Position: Q2 2026 in Review

GAMMA Investing increased its MaxCyte (MXCT) stake by 5% in Q2 2026, buying an estimated $268 and bringing the position to 5,702 shares worth $7.01K. The position accounts for ﹤0.01% of the portfolio, ranked #3349.

GAMMA Investing first reported a position in MXCT in Q1 2026 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • GAMMA Investing held 5,702 shares of MaxCyte worth $7.01K as of Q2 2026.
  • GAMMA Investing bought 269 MaxCyte shares in Q2 2026, an estimated $268.
  • MaxCyte made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3349 holding.
  • GAMMA Investing first reported a position in MaxCyte in Q1 2026 and has held it in 2 quarters since.
  • 8 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.